Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × dehydroftorafur × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 10 Pancreatic Neoplasms 9 Rectal Neoplasms 5 Urinary Bladder Neoplasms 4 Stomach Neoplasms 4 Colonic Neoplasms 4 Adenocarcinoma Of Esophagus 3 Squamous Cell Carcinoma of Head and Neck 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Clinical Stage I Gastric Cancer AJCC v8 2 Appendiceal Neoplasms 2 Anus Neoplasms 2 Uterine Neoplasms 1 Tongue Neoplasms 1 Sinonasal undifferentiated carcinoma 1 Salivary Gland Neoplasms 1 Peritoneal Neoplasms 1 Paranasal Sinus Neoplasms 1 Pancreatic Intraductal Neoplasms 1 PRETEXT I Hepatoblastoma 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Metastatic Small Intestinal Adenocarcinoma 1 Lymphoid Interstitial Pneumonia 1 Laryngeal Neoplasms 1 Keratosis, Actinic 1 Hypopharyngeal Neoplasms 1

Interventions

Nivolumab 63 pembrolizumab 62 cabozantinib 43 Ipilimumab 33 Magnetic Resonance Spectroscopy 30 Specimen Handling 26 lenvatinib 21 Axitinib 20 belzutifan 16 Sunitinib 16 Radiosurgery 13 Biopsy 13 atezolizumab 10 Everolimus 10 CTLA-4 Antigen 10 pazopanib 9 avelumab 8 Radiotherapy 8 Bevacizumab 8 fludarabine 6 cemiplimab 6 aldesleukin 6 Standard of Care 6 Nephrectomy 6 Immunoglobulin G 6 Cyclophosphamide 6 toripalimab 5 spartalizumab 5 Paclitaxel 5 tivozanib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡